Cornerstone Planning Group LLC Royalty Pharma PLC Transaction History
Cornerstone Planning Group LLC
- $407 Billion
- Q4 2024
A detailed history of Cornerstone Planning Group LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 47 shares of RPRX stock, worth $1,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47Holding current value
$1,484% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
412Shares Held
282MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.3 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$727 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$446 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$384 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...